Zynerba Pharma CS (ZYNE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.3000 +0.0300 (+2.36%) 10/10/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.3000 unch (unch) -
for Tue, Oct 10th, 2023
Results
download Want to compare other data? Select Fields| Symbol | ZYNE | ASMB | CPHI | ||
| Company | Zynerba Pharma CS | Assembly Biosciences | China Pharma Holdings | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 1.2600 | 10.27 | 1.3060 | ||
| High | 1.3400 | 10.27 | 1.8100 | ||
| Low | 1.2600 | 9.90 | 1.3000 | ||
| Last | 1.3000 | 10.24 | 1.5100 | ||
| Change | +0.0300 | +0.04 | +0.1100 | ||
| % Change | +2.36% | +0.34% | +7.86% | ||
| Volume | 862,700 | 13,524 | 402,692 | ||
| 20-Day Average Volume | 1,093,995 | 37,677 | 73,234 | ||
| Previous Close | 1.2700 | 10.20 | 1.4000 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.3012 | 9.85 | 2.1427 | ||
| 20-Day Raw Stochastic | 53.49% | 53.35% | 15.15% | ||
| 20-Day Relative Strength | 62.80% | 44.50% | 39.57% | ||
| Weighted Alpha | -35.90 | -37.70 | -43.10 | ||
| Today's Opinion | 80% Buy | 88% Sell | 40% Sell | ||
| Previous Opinion | 80% Buy | 88% Sell | 24% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.17% since 10/03/23 | +19.85% since 04/08/25 | +11.11% since 04/08/25 | ||
| Low | 1.1850 on 10/04/23 | 7.90 on 04/10/25 | 1.2050 on 04/09/25 | ||
| High | 1.3400 on 10/10/23 | 10.36 on 04/14/25 | 1.8100 on 04/15/25 | ||
| 1-Month | |||||
| %Chg | -1.52% since 09/08/23 | -8.84% since 03/14/25 | -38.60% since 03/14/25 | ||
| Low | 1.1850 on 10/04/23 | 7.75 on 04/07/25 | 1.2000 on 04/07/25 | ||
| High | 1.4000 on 09/15/23 | 11.78 on 03/25/25 | 3.1800 on 03/19/25 | ||
| 3-Month | |||||
| %Chg | +293.70% since 07/10/23 | -31.72% since 01/15/25 | -27.88% since 01/15/25 | ||
| Low | 0.2500 on 07/11/23 | 7.75 on 04/07/25 | 1.2000 on 04/07/25 | ||
| High | 1.4000 on 09/15/23 | 14.95 on 01/22/25 | 3.1800 on 03/19/25 | ||
| 6-Month | |||||
| %Chg | +225.00% since 04/10/23 | -46.54% since 10/15/24 | -36.03% since 10/15/24 | ||
| Low | 0.2500 on 07/11/23 | 7.75 on 04/07/25 | 1.2000 on 04/07/25 | ||
| High | 1.4000 on 09/15/23 | 18.98 on 10/18/24 | 3.3500 on 01/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 70,121 | 76,535 | 4,567 | ||
| Shares Outstanding, K | 53,939 | 7,503 | 32,619 | ||
| Annual Sales | 0 | 28,520,000 | 4,530,000 | ||
| Annual Net Income | -35,040,000 | -40,180,000 | -4,740,000 | ||
| Last Quarter Sales | 0 | 7,360,000 | 1,130,000 | ||
| Last Quarter Net Income | -10,780,000 | -10,340,000 | -1,220,000 | ||
| 60-Month Beta | 1.32 | 0.65 | 0.77 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 08/14/23 | -1.57 on 03/20/25 | -0.06 on 11/13/24 | ||
| Latest Earnings Date | 11/13/23 | 05/14/25 | 05/21/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||